| Ident. | Authors (with country if any) | Title |
|---|
| 000212 |
Youchao Dai [République populaire de Chine] ; Yi Cai [République populaire de Chine] ; Xin Wang [République populaire de Chine] ; Jialou Zhu [République populaire de Chine] ; Xiaoqing Liu [République populaire de Chine] ; Houming Liu [République populaire de Chine] ; Linghua Li [République populaire de Chine] ; Yinze Zhang [République populaire de Chine] ; Shengze Liu [République populaire de Chine] ; Zhihua Wen [République populaire de Chine] ; Carl G. Feng [Australie] ; Xinchun Chen [République populaire de Chine] ; Xiaoping Tang [République populaire de Chine] | Autoantibody-Mediated Erythrophagocytosis Increases Tuberculosis Susceptibility in HIV Patients |
| 000227 |
Christopher Kwan [Australie] ; Suzana Milosevic [Australie] ; Helen Benham [Australie] ; Ian A. Scott [Australie] | A rare form of dermatomyositis associated with muscle weakness and normal creatine kinase level |
| 000370 |
Marjorie Reyes-Farias [Espagne] ; Catalina Carrasco-Pozo [Australie] | The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism |
| 000467 |
Zhe Zhang [République populaire de Chine] ; Wei Gao [République populaire de Chine] ; Li Zhou [République populaire de Chine] ; Yan Chen [République populaire de Chine] ; Siyuan Qin [République populaire de Chine] ; Lu Zhang [République populaire de Chine] ; Jiayang Liu [République populaire de Chine] ; Yujia He [République populaire de Chine] ; Yunlong Lei [République populaire de Chine] ; Hai-Ning Chen [République populaire de Chine] ; Junhong Han [République populaire de Chine] ; Zong-Guang Zhou [République populaire de Chine] ; Edouard C. Nice [Australie] ; Changlong Li [République populaire de Chine] ; Canhua Huang [République populaire de Chine] ; Xiawei Wei [République populaire de Chine] | Repurposing Brigatinib for the Treatment of Colorectal Cancer Based on Inhibition of ER-phagy |
| 000707 |
Tu C. Le [Australie] ; Jiali Zhai [Australie] ; Wei-Hsun Chiu [Australie] ; Phong A. Tran [Australie] ; Nhiem Tran [Australie] | Janus particles: recent advances in the biomedical applications |
| 000755 |
Carla Proietti [Australie] ; Lutz Krause [Australie] ; Angela Trieu [Australie] ; Daniel Dodoo [Ghana] ; Ben Gyan [Ghana] ; Kwadwo A. Koram [Ghana] ; William O. Rogers ; Thomas L. Richie ; Peter D. Crompton [États-Unis] ; Philip L. Felgner [États-Unis] ; Denise L. Doolan [Australie] | Immune Signature Against Plasmodium falciparum Antigens Predicts Clinical Immunity in Distinct Malaria Endemic Communities* |
| 000917 |
Stephanie Clare Blake [Australie] ; Benjamin Silas Daniel [Australie] | Cutaneous lupus erythematosus: A review of the literature☆ |
| 000A48 |
Kielan D. Mcalinden ; Deepak A. Deshpande [États-Unis] ; Saeid Ghavami [Canada] ; Dia Xenaki [Australie] ; Sukhwinder Singh Sohal [Australie] ; Brian G. Oliver [Australie] ; Mehra Haghi ; Pawan Sharma [Australie] | Autophagy Activation in Asthma Airways Remodeling. |
| 000A81 |
Ari Satia Nugraha [Australie] ; Yuvita Dian Damayanti ; Phurpa Wangchuk ; Paul A. Keller [Australie] | Anti-Infective and Anti-Cancer Properties of the Annona Species: Their Ethnomedicinal Uses, Alkaloid Diversity, and Pharmacological Activities |
| 000B07 |
Azad Saei [Suède] ; Pieter Johan Adam Eichhorn [Australie, Singapour] | Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma |
| 000B31 |
Jian-Da Ma [République populaire de Chine] ; Jun Jing [République populaire de Chine] ; Jun-Wei Wang [République populaire de Chine] ; Tao Yan [République populaire de Chine] ; Qian-Hua Li [République populaire de Chine] ; Ying-Qian Mo [République populaire de Chine] ; Dong-Hui Zheng [République populaire de Chine] ; Jin-Long Gao [Australie] ; Ky-Anh Nguyen [Australie] ; Lie Dai [République populaire de Chine] | A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients |
| 000C17 |
Oded Breuer [Australie] ; André Schultz [Australie] | Side effects of medications used to treat childhood interstitial lung disease. |
| 000D06 |
Magdalena Circu [États-Unis] ; James Cardelli [États-Unis] ; Martin P. Barr [Irlande (pays)] ; Kenneth O'Byrne [Australie] ; Glenn Mills [États-Unis] ; Hazem El-Osta [États-Unis] | Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells. |
| 000D28 |
Pawan Sharma [États-Unis] ; Roslyn Yi [États-Unis] ; Ajay P. Nayak [États-Unis] ; Nadan Wang [États-Unis] ; Francesca Tang [Australie] ; Morgan J. Knight [États-Unis] ; Shi Pan [États-Unis] ; Brian Oliver [Australie] ; Deepak A. Deshpande [États-Unis] | Bitter Taste Receptor Agonists Mitigate Features of Allergic Asthma in Mice. |
| 000D65 |
Lyn M. Moir [Australie] | Lymphangioleiomyomatosis: Current understanding and potential treatments. |
| 000D75 |
Hui Ren [République populaire de Chine] ; Hua Guo [République populaire de Chine] ; Asmitananda Thakur [République populaire de Chine] ; Shuo Zhang [République populaire de Chine] ; Ting Wang [République populaire de Chine] ; Yiqian Liang [République populaire de Chine] ; Puyu Shi [République populaire de Chine] ; Lei Gao [République populaire de Chine] ; Feng Liu [République populaire de Chine] ; Jing Feng [République populaire de Chine] ; Tianjun Chen [République populaire de Chine] ; Tian Yang [République populaire de Chine] ; Dong Shang [République populaire de Chine] ; Johnson J. Liu [Australie] ; Feng Xu [République populaire de Chine] ; Mingwei Chen [République populaire de Chine] | Blockade efficacy of MEK/ERK-dependent autophagy enhances PI3K/Akt inhibitor NVP-BKM120's therapeutic effectiveness in lung cancer cells. |
| 000D89 |
Teck Choon Tan [Singapour] ; Louise Wienholt [Australie] ; Stephen Adelstein [Australie] | TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia |
| 000E07 |
Erica J. Hines [Australie] ; Mark Walsh [Australie] ; Jane E. Armes [Australie] ; Tonia Douglas [Australie] ; Jasneek Chawla [Australie] | Interstitial lung disease in infancy: A general approach |
| 000E35 |
Jason Kg Tan [Australie] ; Conor Murray ; Andre Schultz [Australie] | ABCA3 lung disease in an ex 27 week preterm infant responsive to systemic glucocorticosteroids |
| 000E44 |
Serena Pulcini [Royaume-Uni] ; Henry M. Staines [Royaume-Uni] ; Andrew H. Lee [États-Unis] ; Sarah H. Shafik [Australie] ; Guillaume Bouyer [France] ; Catherine M. Moore [Royaume-Uni] ; Daniel A. Daley [États-Unis] ; Matthew J. Hoke [États-Unis] ; Lindsey M. Altenhofen [États-Unis] ; Heather J. Painter [États-Unis] ; Jianbing Mu [États-Unis] ; David J P. Ferguson [Royaume-Uni] ; Manuel Llinas [États-Unis] ; Rowena E. Martin [Australie] ; David A. Fidock [États-Unis] ; Roland A. Cooper [États-Unis] ; Sanjeev Krishna [Royaume-Uni] | Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite's food vacuole and alter drug sensitivities |
| 000E68 |
Chayawee Muangchan [Canada] ; Ronald F. Van Vollenhoven [Suède] ; Sasha R. Bernatsky [Canada] ; C Douglas Smith [Canada] ; Marie Hudson [Canada] ; Murat Inanç [Turquie] ; Naomi F. Rothfield ; Peter T. Nash [Australie] ; Richard A. Furie [États-Unis] ; Jean-Luc Senécal [Canada] ; Vinod Chandran [Canada] ; Ruben Burgos-Vargas [Mexique] ; Rosalind Ramsey-Goldman [États-Unis] ; Janet E. Pope [Canada] | Treatment Algorithms in Systemic Lupus Erythematosus. |
| 000E73 |
Yang Xi [Australie] ; Arvid Finlayson [Australie] ; Oliva J. White [Australie] ; Melanie L. Carroll [Australie] ; John W. Upham [Australie] | Rhinovirus stimulated IFN-α production: how important are plasmacytoid DCs, monocytes and endosomal pH? |
| 000F27 |
L. Cummins [Australie] ; V. S. Katikireddi [Australie] ; S. Shankaranarayana [Australie] ; K. Y. C. Su [Australie] ; E. Duggan [Australie] ; V. Videm [Australie, Norvège] ; H. Pahau [Australie] ; R. Thomas [Australie] | Safety and retention of combination triple disease‐modifying anti‐rheumatic drugs in new‐onset rheumatoid arthritis |
| 000F65 |
Melissa Carroll [Australie] ; Nick Mellick [Australie] ; Godfrey Wagner [Australie] | Dermatomyositis panniculitis: A case report |
| 000F73 |
Neil J. Hime [Australie] ; Yvonne Zurynski [Australie] ; Dominic Fitzgerald [Australie] ; Hiran Selvadurai [Australie] ; Amy Phu [Australie] ; Marie Deverell [Australie] ; Elizabeth J. Elliott [Australie] ; Adam Jaffe [Australie] | Childhood interstitial lung disease: A systematic review |
| 000F78 |
Lorenzo Galluzzi [France, Italie] ; Federico Pietrocola [France] ; José Manuel Bravo-San Pedro [France] ; Ravi K. Amaravadi [États-Unis] ; Eric H. Baehrecke [États-Unis] ; Francesco Cecconi [Danemark, Italie] ; Patrice Codogno [France] ; Jayanta Debnath [États-Unis] ; David A. Gewirtz [États-Unis] ; Vassiliki Karantza [États-Unis] ; Alec Kimmelman [États-Unis] ; Sharad Kumar [Australie] ; Beth Levine [États-Unis] ; Maria Chiara Maiuri [France] ; Seamus J. Martin [Irlande (pays)] ; Josef Penninger [Autriche] ; Mauro Piacentini [Italie] ; David C. Rubinsztein [Royaume-Uni] ; Hans-Uwe Simon [Suisse] ; Anne Simonsen [Norvège] ; Andrew M. Thorburn [États-Unis] ; Guillermo Velasco [Espagne] ; Kevin M. Ryan [Royaume-Uni] ; Guido Kroemer [France] | Autophagy in malignant transformation and cancer progression |
| 001006 |
Chantal Donovan ; Mirjam Simoons ; James Esposito ; Jean Ni Cheong ; Meaghan Fitzpatrick ; Jane Elizabeth Bourke [Australie] | Rosiglitazone is a superior bronchodilator compared to chloroquine and β-adrenoceptor agonists in mouse lung slices. |
| 001064 |
Scott W. Graf [Australie] ; Vidya S. Limaye [Australie] ; Leslie G. Cleland [Australie] | Gemcitabine‐induced radiation recall myositis in a patient with dermatomyositis |
| 001127 |
Phurpa Wangchuk ; Wangchuk Phurpa [Australie] ; Paul A. Keller ; Stephen G. Pyne ; Wilford Lie ; Anthony C. Willis ; Roonglawan Rattanajak ; Sumalee Kamchonwongpaisan | A new protoberberine alkaloid from Meconopsis simplicifolia (D. Don) Walpers with potent antimalarial activity against a multidrug resistant Plasmodium falciparum strain. |
| 001261 |
Geoffrey Littlejohn [Australie, États-Unis] ; Lynden Roberts [Australie] ; Mark Arnold [Australie] ; Paul Bird [Australie] ; Simon Burnet [Australie] ; Julien De Jager [Australie] ; Hedley Griffiths [Australie] ; Dave Nicholls [Australie] ; James Scott [Australie] ; Jane Zochling [Australie] ; Kathleen E. Tymms [Australie] | A multi‐center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease control |
| 001316 |
Leann Tilley [Australie, États-Unis] ; Susan A. Charman [Australie, États-Unis] ; Jonathan L. Vennerstrom [Australie, États-Unis] | Chapter 2 - Semisynthetic Artemisinin and Synthetic Peroxide Antimalarials |
| 001323 |
Clare Schofield ; Michael J. Sladden [Australie] | Ulcerative necrobiosis lipoidica responsive to colchicine |
| 001326 |
H. Ahmadzai ; M. C. Kiernan ; D. Wakefield [Australie] ; P. S. Thomas | Treatment of refractory neurosarcoidosis with TNF‐inhibitors: what lies ahead? |
| 001332 |
Niroshini M. Giles [Nouvelle-Zélande] ; Sweta Kumari [Nouvelle-Zélande] ; Bevan P. Gang [Nouvelle-Zélande] ; Chun W. W. Yuen [Australie] ; Emilie M. F. Billaud [Nouvelle-Zélande] ; Gregory I. Giles [Nouvelle-Zélande] | The Molecular Design of S‐Nitrosothiols as Photodynamic Agents for Controlled Nitric Oxide Release |
| 001348 |
J. B. Sartain [Australie] ; N. L. Anderson [Australie] ; J. J. Barry ; P. T. Boyd ; P. W. Howat | Rheumatic heart disease in pregnancy: cardiac and obstetric outcomes |
| 001358 |
V. S. Katikireddi [Australie] ; D. A. Kandiah [Australie] | Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy |
| 001362 |
P. Lees [Royaume-Uni] ; R. P. Hunter [États-Unis] ; P. T. Reeves [Australie] ; P. L. Toutain [France] | Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination |
| 001371 |
D. Tong [Australie] ; N. Manolios [Australie] ; G. Howe ; D. Spencer | New onset sarcoid‐like granulomatosis developing during anti‐TNF therapy: an under‐recognised complication |
| 001391 |
S. Visser [Australie] ; M. Martin [Australie] ; D. J. Serisier [Australie] | Improvements in Cystic Fibrosis Lung Disease and Airway Inflammation Associated with Etanercept Therapy for Rheumatoid Arthritis: A Case Report |
| 001436 |
David Shi Hao Liu ; Emilio Mignanelli [Australie] | Acute surgical abdomen in an immunocompromised patient |
| 001494 |
Trent Conroy [Australie] ; Jin T. Guo [Australie] ; Roger G. Linington [États-Unis] ; Nicholas H. Hunt [Australie] ; Richard J. Payne [Australie] | Total Synthesis, Stereochemical Assignment, and Antimalarial Activity of Gallinamide A |
| 001531 |
Michael F. Good [Australie] | Our impasse in developing a malaria vaccine |
| 001553 |
D. S. A. Mcleod ; M. L. Woods ; D. A. Kandiah [Australie] | Immune reconstitution inflammatory syndrome manifesting as development of multiple autoimmune disorders and skin cancer progression |
| 001564 |
K. Montag [Australie] ; M. Gingold [Australie] ; A. Boers [Australie] ; G. Littlejohn [Australie] | Disease‐modifying anti‐rheumatic drug usage, prescribing patterns and disease activity in rheumatoid arthritis patients in community‐based practice |
| 001571 |
Amy R. Wyatt [Australie] ; Justin J. Yerbury [Australie] ; Paula Berghofer [Australie] ; Ivan Greguric [Australie] ; Andrew Katsifis [Australie] ; Christopher M. Dobson [Royaume-Uni] ; Mark R. Wilson [Australie] | Clusterin facilitates in vivo clearance of extracellular misfolded proteins |
| 001573 |
M. Dugar [Australie] ; S. Cox ; V. Limaye ; P. Blumbergs ; P. J. Roberts-Thomson [Australie] | Clinical heterogeneity and prognostic features of South Australian patients with anti‐synthetase autoantibodies |
| 001586 |
Eva M. Luther [Allemagne] ; Yvonne Koehler [Allemagne] ; Joerg Diendorf [Allemagne] ; Matthias Epple [Allemagne] ; Ralf Dringen [Allemagne, Australie] | Accumulation of silver nanoparticles by cultured primary brain astrocytes |
| 001680 |
M. C. Kennedy [Australie] | Post‐mortem drug concentrations |
| 001689 |
S. J. Butterly ; P. Pillans [Australie] ; B. Horn [Australie] ; R. Miles ; J. Sturtevant | Off‐label use of rituximab in a tertiary Queensland hospital |
| 001793 |
Cyrus Daneshvar [Malaisie] ; Timothy M. E. Davis [Australie] ; Janet Cox-Singh [Malaisie] ; Mohammad Zakri Rafa'Ee [Malaisie] ; Siti Khatijah Zakaria [Malaisie] ; Paul C. S. Divis [Malaisie] ; Balbir Singh [Malaisie] | Clinical and Laboratory Features of Human Plasmodium knowlesi Infection |
| 001848 |
N. Varatharajan [Australie] ; I. G. S. Lim ; A. Anandacoomarasamy ; R. Russo ; K. Byth [Australie] ; D. G. Spencer ; N. Manolios ; G. B. Howe [Australie] | Methotrexate: long‐term safety and efficacy in an Australian consultant rheumatology practice |
| 001854 |
Natasha Behrendorff [Australie] ; Alka Shukla [Australie] ; Christof Schwiening [Royaume-Uni] ; Peter Thorn [Australie] | Local dynamic changes in confined extracellular environments within organs |
| 001870 |
Tj Kleinig [Australie] ; B. Koszyca [Australie] ; Pc Blumbergs [Australie] ; P. Thompson [Australie] | Fulminant leucocytoclastic brainstem vasculitis in a patient with otherwise indolent systemic lupus erythematosus |
| 001941 |
TARWADI [Australie] ; Jalal A. Jazayeri [Australie] ; Richard J. Prankerd [Australie] ; Colin W. Pouton [Australie] | Preparation and in Vitro Evaluation of Novel Lipopeptide Transfection Agents for Efficient Gene Delivery |
| 001943 |
Feiko O. Ter Kuile [Royaume-Uni] ; Stephen J. Rogerson [Australie] | Plasmodium vivax Infection during Pregnancy: An Important Problem in Need of New Solutions |
| 001977 |
Neta Moses [Australie] ; John Wiggers [Australie] ; Craig Nicholas [Australie] | Persistence of unmet need for care among people with systemic lupus erythematosus: a longitudinal study |
| 001A68 |
Nicholas M. Anstey [Australie] ; Tjandra Handojo ; Michael C. F. Pain [Australie] ; Enny Kenangalem [Australie] ; Emiliana Tjitra [Indonésie] ; Ric N. Price [Royaume-Uni] ; Graeme P. Maguire [Australie] | Lung Injury in Vivax Malaria: Pathophysiological Evidence for Pulmonary Vascular Sequestration and Posttreatment Alveolar-Capillary Inflammation |
| 001A70 |
Philip C. Burcham [Australie] ; Albert Raso [Australie] ; Colin Thompson [Australie] ; Dino Tan [Australie] | Intermolecular Protein Cross-Linking During Acrolein Toxicity: Efficacy of Carbonyl Scavengers as Inhibitors of Heat Shock Protein-90 Cross-Linking in A549 Cells |
| 001A71 |
Tina S. Skinner-Adams [Pologne] ; Jonathan Lowther [Pologne] ; Franka Teuscher [Pologne] ; Colin M. Stack [Pologne] ; Jolanta Grembecka [Pologne] ; Artur Mucha [Pologne] ; Pawel Kafarski [Pologne] ; Katharine R. Trenholme [Pologne] ; John P. Dalton [Pologne] ; Donald L. Gardiner [Pologne, Australie] | Identification of Phosphinate Dipeptide Analog Inhibitors Directed against the Plasmodium falciparum M17 Leucine Aminopeptidase as Lead Antimalarial Compounds |
| 001B23 |
Philip J. Thompson [Australie] ; Neil L. Misso [Australie] ; John Woods [Australie] | Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt |
| 001B48 |
Vidya Limaye ; Tim Lu ; Eugene Ang ; Amirtharajan Krishnan ; Pravin Hissaria [Australie] ; David Gillis [Australie] | Granulomatous disease in selective IgA deficiency |
| 001C68 |
S. W. Lim [Australie] ; D. Gillis [Australie] ; W. Smith [Australie] ; P. Hissaria [Australie] ; H. Greville [Australie] ; C. A. Peh [Australie] | Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports |
| 001C72 |
Kayla L. Tran ; Rooshdiya Z. Karim [Australie] ; Paul R. Mckenzie ; Jonathan Stretch [Australie] | Recurrent cutaneous tumour with features of an osteosarcoma: Primary osteosarcoma or cutaneous carcinosarcoma? |
| 001C84 |
R. L. Savage [Australie, Nouvelle-Zélande] ; J. Highton [Australie] ; I. W. Boyd [Australie] ; P. Chapman [Australie] | Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports |
| 001D11 |
Karyn Fuller [Australie] | Interstitial mycosis fungoides initially diagnosed as interstitial granulomatous drug reaction |
| 001D42 |
F L Mastaglia [Australie] | Drug induced myopathies |
| 001D48 |
Karyn Fuller [Australie] | Cutaneous leishmanisis in South Australia – A case series |
| 001D75 |
Emma Storer [Australie] | An atypical panniculitis |
| 001D77 |
Jairam Sastry [Australie] ; Alyson Kakakios [Australie] ; Heidi Tugwell [Australie] ; Peter J. Shaw [Australie] | Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection |
| 001D87 |
Eleni Yiasemides ; Judie Walton ; Penelope Marr ; Elmer V. Villanueva [Australie] ; Dédée F. Murrell | A comparative study between electron microscopy and immunofluorescence mapping in the diagnosis of epidermolysis bullosa |
| 001E62 |
L-T Lim [Australie] ; F. Joshua | Letter to the Editor |
| 001E64 |
Andrew Broadfoot [Australie] ; David Gillis ; Susanna Proudman [Australie] | Lack of association of antineutrophil cytoplasmic antibodies with joint failure as indicated by joint surgery in rheumatoid arthritis |
| 001E73 |
Iain Macintosh [Australie] ; Warwick W. Butt [Australie] ; Colin F. Robertson [Australie] ; Derek Best [Australie] ; Lara S. Shekerdemian [Australie] | Extending the limits of extracorporeal membrane oxygenation: lung rest for a child with non-specific interstitial pneumonia |
| 001E89 |
Grant Masel [Australie] | Copper‐induced cutaneous sarcoidosis |
| 001E99 |
D. Talaulikar [Australie] ; K E Tymms ; I. Prosser [Australie] ; R. Smith [Australie] | Autologous peripheral blood stem cell transplantation with in vivo T-cell depletion for life threatening refractory systemic lupus erythematosus |
| 001F35 |
G. E. M. Reeves [Australie] | Update on the immunology, diagnosis and management of systemic lupus erythematosus |
| 001F87 |
Jonathan L. Vennerstrom [États-Unis] ; Sarah Arbe-Barnes [Royaume-Uni] ; Reto Brun [Suisse] ; Susan A. Charman [Australie] ; Francis C. K. Chiu [Australie] ; Jacques Chollet [Suisse] ; Yuxiang Dong [États-Unis] ; Arnulf Dorn [Suisse] ; Daniel Hunziker [Suisse] ; Hugues Matile [Suisse] ; Kylie Mcintosh [Australie] ; Maniyan Padmanilayam [États-Unis] ; Josefina Santo Tomas [Suisse] ; Christian Scheurer [Suisse] ; Bernard Scorneaux [Suisse] ; Yuanqing Tang [États-Unis] ; Heinrich Urwyler [Suisse] ; Sergio Wittlin [Suisse] ; William N. Charman [Australie] | Identification of an antimalarial synthetic trioxolane drug development candidate |
| 002112 |
F. Z. J. Cai ; M. Rischmueller ; K. Pile ; S. J. Brady [Australie] | Dysphagia associated with lower thoracic spondylosis |
| 002120 |
R. Malik [Australie] ; P. Zunino ; Gb Hunt | Complete heart block associated with lupus in a dog |
| 002125 |
M. Lockshin [États-Unis] ; F. Tenedios [États-Unis] ; M. Petri [États-Unis] ; G. Mccarty [États-Unis] ; R. Forastiero [Argentine] ; S. Krilis [Australie] ; A. Tincani [Italie] ; D. Erkan [États-Unis] ; M A Khamashta [Royaume-Uni] ; Y. Shoenfeld [Israël] | Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report |
| 002182 |
Colin Ong [Australie] ; John Sullivan [Australie] ; Mark Hertzberg [Australie] ; Karen Stapleton [Australie] | Stage IV CD30+ anaplastic large cell lymphoma: Response to acitretin and interferon‐α |
| 002202 |
Navaz Hiramanek ; Steven Kossard [Australie] ; Ross Stc Barnetson | Multicentric reticulohistiocytosis presenting with a rash and arthralgia |
| 002326 |
Catherine Drummond ; Elliott Savdie [Australie] ; Steven Kossard | Sarcoidosis with prominent giant cells |
| 002347 |
J. Alpers [Australie] | Papua and New Guinea medical experiences |
| 002446 |
Janet K. Talbot-Stern [Australie] ; Timothy Green ; Timothy J. Royle | PSYCHIATRIC MANIFESTATIONS OF SYSTEMIC ILLNESS |
| 002479 |
Darren Fernandes [Australie] ; Ross Vlahos [Australie] ; Alastair G. Stewart [Australie] | Thrombin-stimulated DNA Synthesis in Human Cultured Airway Smooth Muscle Occurs Independently of Products of Cyclo-oxygenase or 5-Lipoxygenase |
| 002500 |
Timothy Me Davis [Australie] | Recognition and management of falciparum malaria |
| 002502 |
Julianne T. Djordjevic [Australie] ; Jacqui G. Waterkeyn [Australie] ; Karen L. Hennessy [Australie] ; Keith K. Stanley [Australie] | ROLE OF PHOSPHORYLATION OF THE CYTOPLASMIC DOMAIN OF THE α2-MACROGLOBULIN RECEPTOR (LRP) |
| 002643 |
Narelle R. Bleasel [Australie] ; Karen M. Stapleton [Australie] ; Christopher Commens [Australie] ; Verity A. Ahern [Australie] | Radiation‐induced localized scleroderma in breast cancer patients |
| 002729 |
Rca Thompson [Australie] | Species and strains in the genus Echinococcus - epidemiological and evolutionary perspectives. |
| 002755 |
A. H Fell [États-Unis, Royaume-Uni] ; N. C Smith [Australie] | Immunity to Asexual Blood Stages of Plasmodium : Is Resistance to Acute Malaria Adaptive or Innate? |
| 002819 |
T. M. E. Davis [Australie] ; T. S. Skinner-Adams [Australie] ; J. Beilby [Australie] | In vitro growth inhibition of Plasmodium falciparum by retinol at concentrations present in normal human serum |
| 002940 |
Jodi M. Hilton [Australie] ; David M. Cooper [Australie] ; Richard L. Henry [Australie] | Hydroxychloroquine therapy of diffuse pulmonary sarcoidosis in two Australian male children |
| 002997 |
G. Jones ; P. M. Brooks [Australie] | INJECTABLE GOLD COMPOUNDS: AN OVERVIEW |
| 002A88 |
Robert Booy [Royaume-Uni] ; Michael Pearce [Indonésie] ; John Sheridan [Australie] ; Wendy Holmes [Australie] | Outbreak of group C meningococcal disease in Australian Aboriginal children |
| 002C47 |
M. A. Myers [Australie] ; H. H. Salem [Australie] ; P. Bird [Australie] | Construction and characterization of a chimeric protein consisting of tissue-type plasminogen activator and the epidermal growth factor-like regions of thrombomodulin |
| 002C55 |
Ron Lawford [Australie] ; Tania C. Sorrell [Australie] | Amebic Abscess of the Spleen Complicated by Metronidazole-Induced Neurotoxicity: Case Report |
| 002C75 |
Peter Upcroft [Australie] | Multiple drug resistance in the pathogenic protozoa |
| 002D35 |
Amanda S. Y. Lim [Australie] ; Alan F. Cowman [Australie] | Phosphorylation of a P-glycoprotein homologue in Plasmodium falciparum |
| 002E58 |
K. E. Aziz ; P. J. Mccluskey ; A. Montanaro [États-Unis] ; D. Wakefield [Australie] | SjöUgren's syndrome: review with recent insights into immunopathogenesis |
| 002F11 |
Steven Karcz [Australie] ; Alan F. Cowman [Australie] | Similarities and differences between the multidrug resistance phenotype of mammalian tumor cells and chloroquine resistance in Plasmodium falciparum |
| 002F57 |
K. A. Waters [Australie] ; P. Bale [Australie] ; D. Isaacs [Australie] ; C. Mellis [Australie] | Successful chloroquine therapy in a child with lymphoid interstitial pneumonitis |
| 003035 |
Kenneth M. Williams [Australie] | Enantiomers in arthritic disorders |
| 003036 |
Pamela J. Russell [Australie] ; Shaun M. O'Mara [Australie] ; Derek Raghavan [Australie] | Ectopic hormone production by small cell undifferentiated carcinomas |
| 003090 |
Gilda Civitico [Australie] ; Yanyan Wang [Australie] ; Carolyn Luscombe [Australie] ; Naomi Bishop [Australie] ; Gilda Tachedjian [Australie] ; Ian Gust [Australie] ; Stephen Locarnini [Australie] | Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B Virus in vitro using conventional antiviral agents and supercoiled‐DNA active compounds |
| 003216 |
Frank Shann [Australie] | CLINICAL SIGNS OF PNEUMONIA IN CHILDREN |
| 003232 |
Anna C. Macintyre [Australie] ; David J. Cutler [Australie] | The potential role of lysosomes in tissue distribution of weak bases |
| 003339 |
David T. Ransom [Australie] ; Fiona G. Cameron M. B. Ch. B. [Australie] | Scleroderma – A Possible Contra‐Indication to Lumpectomy and Radiotherapy in Breast Carcinoma |
| 003417 |
P. J. Robinson [Australie] ; A. Olinsky [Australie] | Sarcoidosis in children |
| 003455 |
J. G. Kench [Australie] ; J. P. Seale [Australie] ; D. M. Temple [Australie] ; C. Tennant [Australie] | The effects of non-steroidal inhibitors of phospholipase Az on leukotriene and histamine release from human and guinea-pig lung |
| 003499 |
C. J. Needs [Australie] ; P. M. Brooks [Australie] | ANTIRHEUMATIC MEDICATION IN PREGNANCY |
| 003577 |
J. G. Kench [Australie] ; J. P. Seale [Australie] ; Diana M. Temple [Australie] ; Carolyn Tennant [Australie] | Chloroquine inhibits leukotriene release from human and guinea-pig lung fragments |
| 003702 |
A. Manoharan [Australie] ; D. Painter [Australie] | HISTIOCYTIC MEDULLARY RETICULOSIS |
| 003817 |
Rodney F. Minchin [Australie] ; Barry W. Madsen [Australie] | Inhibition of chlorphentermine binding in rat lung: Application of connectivity theory |
| 003851 |
D. Handelsman [Australie] ; D. K. Yue [Australie] ; J. R. Turtle [Australie] ; J. G. M. Klijn [Pays-Bas] ; S. W. J. Lamberts [Pays-Bas] ; J. C. Birkenh Ger [Pays-Bas] | TRH TEST FOR PROLACTINOMA |
| 003862 |
Barbara Field [Australie] ; Charles Kerr [Australie] | HERBICIDE USE AND INCIDENCE OF NEURAL-TUBE DEFECTS |
| 003997 |
K. Unsicker [Australie] ; I. J. Allan [Australie] ; D. F. Newgreen [Australie] | Extraneuronal effects of 6-hydroxydopamine and extraneuronal uptake of noradrenaline |
| 003A14 |
R. W. Pain [Australie] ; P. J. Phillips [Australie] | POTASSIUM SUPPLEMENTATION OF THIAZIDE THERAPY |
| 003C44 |
J. K. Dawborn [Australie] ; A. E. Doyle [Australie] ; A. Ebringer [Australie] ; June Howqua [Australie] ; G. Jerums [Australie] ; C. I. Johnston [Australie] ; M. L. Mashford [Australie] ; J. D. Parkin [Australie] | Persistent postural hypotension due to guanacline |
| 003D70 |
Brian R. Entwisle [Australie] | ACRODERMATITIS ENTEROPATHICA |
| 003E43 |
H. O. Lancaster [Australie] | DEATH CERTIFICATION IN DIABETES |
